78 related articles for article (PubMed ID: 21939752)
1. Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: involvement of the p38 MAPK.
Reddi D; Brown SJ; Belibasakis GN
Microb Pathog; 2011 Dec; 51(6):415-20. PubMed ID: 21939752
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells.
Reddi D; Bostanci N; Hashim A; Aduse-Opoku J; Curtis MA; Hughes FJ; Belibasakis GN
Microbes Infect; 2008; 10(14-15):1459-68. PubMed ID: 18789397
[TBL] [Abstract][Full Text] [Related]
3. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
5. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS
Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB; Lerner UH
Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
[TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
Oikawa A; Kobayashi M; Okamatsu Y; Shinki T; Kamijo R; Yamamoto M; Hasegawa K
J Periodontal Res; 2007 Aug; 42(4):367-76. PubMed ID: 17559635
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells.
Krajewski AC; Biessei J; Kunze M; Maersch S; Perabo L; Noack MJ
APMIS; 2009 Oct; 117(10):746-54. PubMed ID: 19775343
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases.
Rösch S; Ramer R; Brune K; Hinz B
Biochem Biophys Res Commun; 2005 Dec; 338(2):1171-8. PubMed ID: 16256948
[TBL] [Abstract][Full Text] [Related]
11. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways in osteoblast proinflammatory responses to infection by Porphyromonas gingivalis.
Ohno T; Okahashi N; Morisaki I; Amano A
Oral Microbiol Immunol; 2008 Apr; 23(2):96-104. PubMed ID: 18279176
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis induces RANKL in T-cells.
Belibasakis GN; Reddi D; Bostanci N
Inflammation; 2011 Apr; 34(2):133-8. PubMed ID: 20446027
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
16. Impact of Porphyromonas gingivalis inoculation on ligature-induced alveolar bone loss. A pilot study in rats.
Meulman T; Peruzzo DC; Stipp RN; Gonçalves PF; Sallum EA; Casati MZ; Goncalves RB; Nociti FH
J Periodontal Res; 2011 Oct; 46(5):629-36. PubMed ID: 21726226
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss.
Sasaki H; Okamatsu Y; Kawai T; Kent R; Taubman M; Stashenko P
J Periodontal Res; 2004 Dec; 39(6):432-41. PubMed ID: 15491348
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways.
Le XK; Laflamme C; Rouabhia M
Indian J Dent Res; 2009; 20(2):141-9. PubMed ID: 19553712
[TBL] [Abstract][Full Text] [Related]
20. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.
Corallini F; Celeghini C; Rimondi E; di Iasio MG; Gonelli A; Secchiero P; Zauli G
J Cell Physiol; 2011 Sep; 226(9):2279-86. PubMed ID: 21660951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
